Literature DB >> 10428902

Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.

P Mondon1, R Petter, G Amalfitano, R Luzzati, E Concia, I Polacheck, K J Kwon-Chung.   

Abstract

Cryptococcus neoformans isolates that exhibited unusual patterns of resistance to fluconazole and voriconazole were isolated from seven isolates from two different geographical regions: one isolate from an Israeli non-AIDS patient and six serial isolates from an Italian AIDS patient who had suffered six recurrent episodes of cryptococcal meningitis. Each isolate produced cultures with heterogeneous compositions in which most of the cells were susceptible, but cells highly resistant to fluconazole (MICs, >/=64 microg/ml) were recovered at a variable frequency (7 x 10(-3) to 4.6 x 10(-2)). Evidence showed that this type of resistance is innate and is unrelated to drug exposure since the Israeli patient had never been treated with azoles or any other antimycotic agents. Analysis of clonal subpopulations of these two strains showed that they exhibited heterogeneous patterns of resistance. The number of subpopulations which grew on fluconazole or voriconazole agar declined progressively with increasing azole concentration without a sharp cutoff point. For the Italian serial isolates, the number of clonal populations resistant to fluconazole (64 microg/ml) and voriconazole (1 microg/ml) increased steadily, yielding the highest number for the isolate from the last episode. Attempts to purify a sensitive subpopulation failed, but clones highly resistant to fluconazole (100 microg/ml) and moderately resistant to voriconazole (1 microg/ml) always produced a homogeneous population of resistant cells. Upon maintenance on drug-free medium, however, the majority of the homogeneously resistant cells of these subclones lost their resistance and returned to the stable initial heteroresistant phenotype. The pattern of heteroresistance was not affected by the pH or osmolarity of the medium but was influenced by temperature. The resistance appeared to be suppressed at 35 degrees C and was completely abolished at 40 degrees C. Although heterogeneity in azole resistance among subpopulations of single isolates has been reported for Candida species, the transient changes in expression of resistance under different growth conditions reported here have not been observed in fungal pathogens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428902      PMCID: PMC89380     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.

Authors:  M A Pfaller; J Zhang; S A Messer; M E Brandt; R A Hajjeh; C J Jessup; M Tumberland; E K Mbidde; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  Genetic control of population structure in heterogeneous strains of methicillin resistant Staphylococcus aureus.

Authors:  H de Lencastre; A M Figueiredo; A Tomasz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

3.  Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus.

Authors:  C Ryffel; A Strässle; F H Kayser; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

4.  Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.

Authors:  A Casadevall; E D Spitzer; D Webb; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

5.  Persistence of initial infection in recurrent Cryptococcus neoformans meningitis.

Authors:  E D Spitzer; S G Spitzer; L F Freundlich; A Casadevall
Journal:  Lancet       Date:  1993-03-06       Impact factor: 79.321

6.  Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis.

Authors:  J D Velez; R Allendoerfer; M Luther; M G Rinaldi; J R Graybill
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

7.  Cloning and characterization of a gene affecting the methicillin resistance level and the autolysis rate in Staphylococcus aureus.

Authors:  H Maki; T Yamaguchi; K Murakami
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

8.  Susceptibility testing of Cryptococcus neoformans: a microdilution technique.

Authors:  M A Ghannoum; A S Ibrahim; Y Fu; M C Shafiq; J E Edwards; R S Criddle
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

9.  Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus.

Authors:  B J Hartman; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

10.  Formation of a minichromosome in Cryptococcus neoformans as a result of electroporative transformation.

Authors:  A Varma; K J Kwon-Chung
Journal:  Curr Genet       Date:  1994-07       Impact factor: 3.886

View more
  54 in total

1.  CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans.

Authors:  Y C Chang; A Jong; S Huang; P Zerfas; K J Kwon-Chung
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment.

Authors:  Edward Sionov; Yun C Chang; Kyung J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

Review 3.  Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Authors:  Leah E Cowen; William J Steinbach
Journal:  Eukaryot Cell       Date:  2008-03-28

4.  Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans.

Authors:  J Xu; C Onyewu; H J Yoell; R Y Ali; R J Vilgalys; T G Mitchell
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

5.  Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation.

Authors:  Popchai Ngamskulrungroj; Yun Chang; Bryan Hansen; Cliff Bugge; Elizabeth Fischer; Kyung J Kwon-Chung
Journal:  FEMS Yeast Res       Date:  2012-07-18       Impact factor: 2.796

6.  Large-Scale Chromosomal Changes and Associated Fitness Consequences in Pathogenic Fungi.

Authors:  Anja Forche
Journal:  Curr Fungal Infect Rep       Date:  2014-06-01

7.  Mycobacterium tuberculosis Subculture Results in Loss of Potentially Clinically Relevant Heteroresistance.

Authors:  John Z Metcalfe; Elizabeth Streicher; Grant Theron; Rebecca E Colman; Renee Penaloza; Christopher Allender; Darrin Lemmer; Robin M Warren; David M Engelthaler
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

8.  Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.

Authors:  Edward Sionov; Hyeseung Lee; Yun C Chang; Kyung J Kwon-Chung
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

9.  Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment.

Authors:  Miwha Chang; Edward Sionov; Ami Khanal Lamichhane; Kyung J Kwon-Chung; Yun C Chang
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 10.  Rapid mechanisms for generating genome diversity: whole ploidy shifts, aneuploidy, and loss of heterozygosity.

Authors:  Richard J Bennett; Anja Forche; Judith Berman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-31       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.